$VXRT News

Vaxart, Inc. (VXRT) Q1 2026 Earnings Call Transcript

Vaxart Q1 EPS $0.02 Beats $(0.01) Estimate, Sales $39.227M Miss $65.500M Estimate

Vaxart Enters Share Purchase Agreement With Lincoln Park Capital For Up To $25M Of Stock

Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript

Vaxart, Inc. (VXRT) Q4 2025 Earnings Call Transcript

Vaxart Q4 EPS $0.24 Beats $(0.05) Estimate, Sales $104.239M Beat $69.700M Estimate

Vaxart, Inc. (VXRT) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference - Slideshow

Vaxart Publishes Data From Phase 1 Study Of Single-Dose, Oral Bivalent Vaccine Candidate In Post-Partum, Breastfeeding Women

Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript

Vaxart Inc (VXRT) Q3 2025 Earnings Call Highlights: Strategic Partnership and Revenue Surge ...

Vaxart, Inc. (VXRT) Q3 2025 Earnings Call Transcript

Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results

Vaxart (OTC: VXRT) Q3 EPS $(0.04) Up From $(0.06) YoY, Sales $72.41M Up From $4.93M YoY

A Look at Vaxart's Upcoming Earnings Report

4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates

Vaxart to Host Upcoming Conference Calls

Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025

Vaxart Announces Withdrawal of Reverse Stock Split Proposal

Vaxart Withdraws Its Reverse Stock Split Proposal

Concerned Vaxart Stockholders Respond to Inadequate Governance Announcements